These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23913810)

  • 1. The TP73 complex network: ready for clinical translation in cancer?
    Soldevilla B; Millán CS; Bonilla F; Domínguez G
    Genes Chromosomes Cancer; 2013 Nov; 52(11):989-1006. PubMed ID: 23913810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of the deregulated TP73 isoforms expression in cancer.
    Rodríguez N; Peláez A; Barderas R; Domínguez G
    Clin Transl Oncol; 2018 Jul; 20(7):827-836. PubMed ID: 29230693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating p73 isoforms in human tumours.
    Coates PJ
    J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
    Hassan HM; Dave BJ; Singh RK
    Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the TP73 gene and its transcripts in neuro-oncology.
    Jancalek R
    Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas.
    Díaz R; González-Sancho JM; Soldevilla B; Silva J; García JM; García V; Peña C; Herrera M; Gómez I; Bonilla F; Domínguez G
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1135-42. PubMed ID: 20842728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.
    Soldevilla B; Díaz R; Silva J; Campos-Martín Y; Muñoz C; García V; García JM; Peña C; Herrera M; Rodriguez M; Gómez I; Mohamed N; Marques MM; Bonilla F; Domínguez G
    Clin Cancer Res; 2011 Sep; 17(18):6029-39. PubMed ID: 21807636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 family members and human cancers.
    Bénard J; Douc-Rasy S; Ahomadegbe JC
    Hum Mutat; 2003 Mar; 21(3):182-91. PubMed ID: 12619104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.
    Wager M; Guilhot J; Blanc JL; Ferrand S; Milin S; Bataille B; Lapierre F; Denis S; Chantereau T; Larsen CJ; Karayan-Tapon L
    Br J Cancer; 2006 Oct; 95(8):1062-9. PubMed ID: 17047653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
    Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
    J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors.
    Candi E; Agostini M; Melino G; Bernassola F
    Hum Mutat; 2014 Jun; 35(6):702-14. PubMed ID: 24488880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy.
    Costanzo A; Pediconi N; Narcisi A; Guerrieri F; Belloni L; Fausti F; Botti E; Levrero M
    FEBS Lett; 2014 Aug; 588(16):2590-9. PubMed ID: 24983500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNp73 a matter of cancer: mechanisms and clinical implications.
    Buhlmann S; Pützer BM
    Biochim Biophys Acta; 2008 Apr; 1785(2):207-16. PubMed ID: 18302944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.